EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
6.1.2.1 | D-alanine | substrate inhibition | Streptomyces coelicolor |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.1.2.1 | D-alanine + (R)-lactate + ATP | Streptomyces coelicolor | - |
D-alanyl-(R)-lactate + ADP + phosphate | - |
? | |
6.1.2.1 | D-alanine + (R)-lactate + ATP | Streptomyces coelicolor ATCC BAA-471 | - |
D-alanyl-(R)-lactate + ADP + phosphate | - |
? | |
6.1.2.1 | D-alanine + (R)-lactate + ATP | Streptomyces coelicolor M145 | - |
D-alanyl-(R)-lactate + ADP + phosphate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.13.22 | Streptomyces coelicolor | - |
- |
- |
3.4.13.22 | Streptomyces coelicolor ATCC BAA-471 | - |
- |
- |
6.1.2.1 | Streptomyces coelicolor | - |
- |
- |
6.1.2.1 | Streptomyces coelicolor M145 | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.1.2.1 | D-alanine + (R)-lactate + ATP | - |
Streptomyces coelicolor | D-alanyl-(R)-lactate + ADP + phosphate | - |
? | |
6.1.2.1 | D-alanine + (R)-lactate + ATP | - |
Streptomyces coelicolor ATCC BAA-471 | D-alanyl-(R)-lactate + ADP + phosphate | - |
? | |
6.1.2.1 | D-alanine + (R)-lactate + ATP | - |
Streptomyces coelicolor M145 | D-alanyl-(R)-lactate + ADP + phosphate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
6.1.2.1 | D-Ala-D-Lac ligase | - |
Streptomyces coelicolor |
6.1.2.1 | D-alanyl-D-lactate ligase | - |
Streptomyces coelicolor |
6.1.2.1 | VanA | - |
Streptomyces coelicolor |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
6.1.2.1 | ATP | - |
Streptomyces coelicolor |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.4.13.22 | physiological function | exogenous D-Ala competes with D-Lac as a substrate for ligase VanA and reduces vancomycin resistance. The effect is augmented by several orders of magnitude in the absence of the D-Ala-D-Ala peptidase VanX. High concentrations of D-Ala lead to the production of a significant amount of wild-type cell wall precursors, while vanX-null mutants produce primarily wild-type precursors. This enhances the efficacy of vancomycin in the vancomycin-resistant model organism Streptomyces coelicolor, and the susceptibility of vancomycin-resistant clinical isolates of Enterococcus faecium increases by up to 100fold. The enhanced vancomycin sensitivity of Streptomyces coelicolor cells correlates directly to increased binding of the antibiotic to the cell wall | Streptomyces coelicolor |